What does this research mean for the field?

Early initiation of cyclosporine A is a potentially effective therapeutic option for Mycoplasma pneumoniae-induced rash and mucositis (MIRM) that can lead to rapid clinical resolution. Novelty: ClaimNovelty.NOVEL_FINDING. Consensus alignment: ConsensusAlignment.NEUTRAL.

September 10, 2019Journal of Cutaneous Medicine and Surgery

Treatment of Mycoplasma pneumoniae -Induced Rash and Mucositis With Cyclosporine

View Full Paper

Ask AI

Bookmark

Authors

HLHeidi Oi‐Yee Li SCSophia Colantonio MRMichele Ramien

Discussion

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Li et al. (2019) studied this question.

synapsesocial.com/papers/6a5e2bbddec751667c70b2cb https://doi.org/10.1177/1203475419874444

View Full Paper

Ask AI

Bookmark

September 10, 2019Journal of Cutaneous Medicine and Surgery

Treatment of Mycoplasma pneumoniae -Induced Rash and Mucositis With Cyclosporine

View Full Paper

Ask AI

Bookmark

Authors

HLHeidi Oi‐Yee Li SCSophia Colantonio MRMichele Ramien

Discussion

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Li et al. (2019) studied this question.

synapsesocial.com/papers/6a5e2bbddec751667c70b2cb https://doi.org/10.1177/1203475419874444

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

View Full Paper

Ask AI

Bookmark